NEW YORK – Angiosarcoma, a rare cancer that materializes in the inner lining of blood vessels, occurs in about 300 patients a year in the US. Because of the relatively low case numbers and the geographic dispersion of patients, the disease has been notoriously difficult to study, according to Corrie Painter, the associate director of operations and scientific outreach for the Broad Institute's Cancer Program.
Angiosarcoma Research, Drug Trials Get Boost From Grassroots Effort Collecting Samples From Patients
Premium
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.